<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>An explainable framework for the relationship between dementia and glucose metabolism patterns - Health AI Hub</title>
    <meta name="description" content="This paper introduces a semi-supervised Variational Autoencoder (VAE) framework to model the intricate relationship between high-dimensional neuroimaging data a">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>An explainable framework for the relationship between dementia and glucose metabolism patterns</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2601.20480v1" target="_blank">2601.20480v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2026-01-28
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> C. V√°zquez-Garc√≠a, F. J. Mart√≠nez-Murcia, F. Segovia Rom√°n, A. Forte, J. Ram√≠rez, I. Ill√°n, A. Hern√°ndez-Segura, C. Jim√©nez-Mesa, Juan M. G√≥rriz
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG, q-bio.NC
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2601.20480v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2601.20480v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces a semi-supervised Variational Autoencoder (VAE) framework to model the intricate relationship between high-dimensional neuroimaging data and dementia progression. By aligning specific latent variables with clinical cognitive scores, the framework effectively extracts interpretable disease-related patterns, revealing reduced glucose metabolism in key brain regions like the hippocampus and within the Default Mode and Central Executive Networks.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This framework offers an interpretable computational approach to disentangle complex neurobiological changes in dementia, potentially enabling earlier and more accurate identification of disease progression, and fostering a deeper understanding of underlying glucose metabolic dysfunction in neurodegeneration.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The research develops an explainable AI framework (semi-supervised Variational Autoencoder) to analyze medical neuroimaging data (PET scans) for understanding the relationship between glucose metabolism and dementia progression. This application helps in identifying disease-related patterns, validating biomarkers, and potentially predicting or monitoring the progression of neurodegenerative diseases like Alzheimer's, making it a direct medical AI application for disease understanding and diagnosis/prognosis support.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Proposes a semi-supervised VAE framework for analyzing high-dimensional neuroimaging data in neurodegenerative diseases.</li>
                    
                    <li>Utilizes a flexible similarity regularization term to align selected latent variables with clinical or biomarker measures of dementia progression.</li>
                    
                    <li>Demonstrated using PET scans from the Alzheimer's Disease Neuroimaging Initiative (ADNI), guiding the first latent dimension to align with a cognitive score.</li>
                    
                    <li>Voxel-wise GLM analysis on average reconstructions revealed significant reduced glucose metabolism in critical regions, particularly the hippocampus.</li>
                    
                    <li>Identified reduced metabolism within major Resting State Networks, specifically the Default Mode Network (DMN) and the Central Executive Network (CEN).</li>
                    
                    <li>The remaining latent variables capture confounds such as affine transformations, intensity variations, inter-subject variability, and site effects.</li>
                    
                    <li>Offers an interpretable and adaptable tool for extracting disease-related patterns aligned with established Alzheimer's biomarkers.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>A semi-supervised Variational Autoencoder (VAE) framework is proposed, incorporating a flexible similarity regularization term. This term aligns specific latent variables within the VAE's lower-dimensional space with external clinical or biomarker measures of disease progression. The method was applied to PET scans from the ADNI dataset, where the first latent dimension was supervised to align with a cognitive score. Subsequently, voxel-wise Generalized Linear Model (GLM) analysis was performed on average brain reconstructions, generated across different levels of cognitive impairment, to identify significant metabolic changes.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>['The supervised first latent variable successfully aligned with a cognitive score, allowing for the generation of average brain reconstructions representative of varying cognitive impairment levels.', 'GLM analysis of these reconstructions revealed significant reduced glucose metabolism in key brain regions, most notably the hippocampus.', 'Reduced metabolism was also observed within major Resting State Networks, specifically the Default Mode Network (DMN) and the Central Executive Network (CEN).', 'The remaining unsupervised latent variables effectively captured other sources of variability in the imaging data, including affine transformations, intensity variations, inter-subject differences, and scanner site effects, providing a cleaner signal for disease-specific patterns.']</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This framework could significantly enhance the diagnostic and prognostic assessment of dementia by providing an interpretable, data-driven method to identify early and subtle patterns of metabolic decline from neuroimaging data. It has the potential to aid in monitoring disease progression, improving patient stratification for clinical trials, and contributing to the development of more targeted therapeutic interventions by pinpointing specific brain regions and networks critically affected by glucose hypometabolism related to cognitive decline.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state specific limitations of the proposed framework or its application.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly state future research directions for this work.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neurology</span>
                    
                    <span class="tag">Radiology</span>
                    
                    <span class="tag">Geriatrics</span>
                    
                    <span class="tag">Neuroscience</span>
                    
                    <span class="tag">Computational Medicine</span>
                    
                    <span class="tag">Neurodegenerative Diseases</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Dementia</span>
                    
                    <span class="tag tag-keyword">Glucose Metabolism</span>
                    
                    <span class="tag tag-keyword">PET Imaging</span>
                    
                    <span class="tag tag-keyword">Variational Autoencoder (VAE)</span>
                    
                    <span class="tag tag-keyword">Neuroimaging</span>
                    
                    <span class="tag tag-keyword">Alzheimer's Disease</span>
                    
                    <span class="tag tag-keyword">Cognitive Impairment</span>
                    
                    <span class="tag tag-keyword">Machine Learning</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">High-dimensional neuroimaging data presents challenges for assessing neurodegenerative diseases due to complex non-linear relationships. Variational Autoencoders (VAEs) can encode scans into lower-dimensional latent spaces capturing disease-relevant features. We propose a semi-supervised VAE framework with a flexible similarity regularization term that aligns selected latent variables with clinical or biomarker measures of dementia progression. This allows adapting the similarity metric and supervised variables to specific goals or available data. We demonstrate the approach using PET scans from the Alzheimer's Disease Neuroimaging Initiative (ADNI), guiding the first latent dimension to align with a cognitive score. Using this supervised latent variable, we generate average reconstructions across levels of cognitive impairment. Voxel-wise GLM analysis reveals reduced metabolism in key regions, mainly the hippocampus, and within major Resting State Networks, particularly the Default Mode and Central Executive Networks. The remaining latent variables encode affine transformations and intensity variations, capturing confounds such as inter-subject variability and site effects. Our framework effectively extracts disease-related patterns aligned with established Alzheimer's biomarkers, offering an interpretable and adaptable tool for studying neurodegenerative progression.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>